Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-038431

Director acquired 100 shares (code L)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PATOU GARY Director 2021-03-17 Other acquisition +100 $19.49 $1,949 100 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
PATOU GARY Director 2021-06-03 Grant or award · Stock Option (Right to Buy) +10,000 10,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…